# Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

> **NCT01602445** · — · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 700 (estimated)

## Conditions studied

- Venous Thromboembolism
- Deep-Vein Thrombosis
- Pulmonary Embolism
- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01602445
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2017-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01602445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01602445, "Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01602445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*